Drug Price Trends for SENNA-TIME

Average Pharmacy Cost for SENNA-TIME

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
SENNA-TIME 8.6 MG TABLET	49483-0080-10	0.02552	EACH	2025-04-23
SENNA-TIME S TABLET	49483-0081-10	0.03085	EACH	2025-04-23
SENNA-TIME S TABLET	49483-0081-01	0.03085	EACH	2025-04-23
SENNA-TIME 8.6 MG TABLET	49483-0080-01	0.02552	EACH	2025-04-23
SENNA-TIME 8.6 MG TABLET	49483-0080-10	0.02511	EACH	2025-03-19

Market Analysis and Price Projections for Sennosides (Senna-Time)

Introduction to Sennosides

Sennosides, commonly known as Senna or Senna glycosides, are natural laxatives derived from the leaves of the Senna alexandrina plant. These compounds are widely used to treat constipation, prepare the bowel for surgical procedures, and clean the intestine before a colonoscopy[1][3].

Global Market Size and Growth

The global sennosides market is anticipated to experience significant growth over the next decade. As of 2023, the market is valued at approximately $359.5 million and is projected to reach $548.5 million by 2033, growing at a Compound Annual Growth Rate (CAGR) of 4.3% during this period[1].

Market Drivers

Several factors are driving the growth of the sennosides market:

• Increasing Prevalence of Gastrointestinal Disorders: The rising incidence of constipation and other gastrointestinal disorders globally is a major driver. Constipation affects a significant portion of the population and can result from various factors, including lifestyle changes and drug overuse[1][3].
• Changes in Lifestyle and Dietary Habits: The hectic schedules and irregular eating patterns of modern lifestyles contribute to gastrointestinal issues, boosting the demand for sennosides[3].
• Surgical and Medical Procedures: The use of sennosides to clean the bowel before surgeries and colonoscopies also contributes to market growth[1][3].

Market Segmentation

The sennosides market can be segmented based on several criteria:

• Drug Type: Sennosides dominate the market with a share of around 71.7%, due to their easy availability and low cost[1].
• Dosage Type: Sennosides are administered orally or rectally, with the oral route being the most common form of administration[3].
• Application: Sennosides are used for treating constipation, irritable bowel syndrome, hemorrhoids, and preparing the bowel for surgeries and colonoscopies[3].
• Distribution Channel: The market is distributed through various channels, including pharmacies, hospitals, and online platforms[1].

Regional Outlook

Geographically, the sennosides market is divided into several regions:

• Asia-Pacific: This region is expected to dominate the global market due to the high population and increasing prevalence of gastrointestinal disorders in countries like India and China[3].
• North America and Europe: These regions also hold significant market shares, driven by the high demand for sennosides in treating constipation and other gastrointestinal issues[1].

Price Projections and Spending Trends

The cost of sennosides is relatively low compared to other prescription drugs, which contributes to their widespread use.

• Retail Prescription Drug Spending: While the overall retail prescription drug spending is expected to moderate in the next decade, the specific costs of sennosides are likely to remain stable due to their generic and over-the-counter (OTC) availability[2].
• Out-of-Pocket Spending: The Inflation Reduction Act of 2022 includes provisions that cap out-of-pocket prescription drug spending, which may indirectly affect the pricing dynamics of sennosides, although these provisions are primarily aimed at Medicare beneficiaries[2].

Challenges and Restraints

Despite the growth potential, the sennosides market faces some challenges:

• Adverse Effects: Sennosides can cause side effects such as stomach pain, headache, and nausea, which can restrain market growth[3].
• Contraindications: The drug is contraindicated for patients with diarrhea or during pregnancy, limiting its use in certain populations[3].

Impact of COVID-19

The COVID-19 pandemic had a positive impact on the sennosides market. Lockdowns and restricted movements led to changes in eating habits and lifestyle, resulting in an increase in gastrointestinal disorders and subsequently boosting the demand for sennosides[3].

Key Takeaways

• The global sennosides market is expected to grow at a CAGR of 4.3% from 2023 to 2033.
• The market is driven by the increasing prevalence of gastrointestinal disorders and changes in lifestyle and dietary habits.
• Asia-Pacific is expected to dominate the market due to the high population and rising incidence of gastrointestinal issues.
• Despite the growth, the market faces challenges such as adverse effects and contraindications.

FAQs

1. What is the projected market value of the sennosides market by 2033? The sennosides market is projected to reach a valuation of $548.5 million by 2033[1].

2. What are the primary drivers of the sennosides market? The primary drivers include the increasing prevalence of gastrointestinal disorders, changes in lifestyle and dietary habits, and the use of sennosides in surgical and medical procedures[1][3].

3. Which region is expected to dominate the sennosides market? The Asia-Pacific region is expected to dominate the global sennosides market due to the high population and rising incidence of gastrointestinal issues in countries like India and China[3].

4. What are the common side effects of sennosides? Common side effects include stomach pain, headache, and nausea[3].

5. How has the COVID-19 pandemic affected the sennosides market? The pandemic has had a positive impact on the market by increasing the incidence of gastrointestinal disorders due to changes in lifestyle and dietary habits during lockdowns[3].

Cited Sources

1. Future Market Insights: Sennosides Market Size, Share, Trend & Outlook by 2033.
2. Health System Tracker: Recent and Forecasted Trends in Prescription Drug Spending.
3. PharmiWeb: Sennosides Market totaling a market valuation of US$ 527.9 Mn by 2032.
4. Business Research Insights: Senna Leaf Extracts Market Share | 2024 To 2031 Global Report.
5. CMS: Negotiated Prices for Initial Price Applicability Year 2026.